Property | Value |
Name | The Impact of Operator Education Level on the Safety and Tolerability of Transcranial Magnetic Stimulation |
Description | Original Research Article
The Food and Drug Administration (FDA) approved the NeuroStar Transcranial Magnetic Stimulation Therapy system for the treatment of major depressive disorder in the fall of 2008. Since that time more than 175 devices have been placed in both public and private practice settings. Transcranial Magnetic Stimulation (TMS) therapy requires psychiatric prescription and supervision, however there are no specific standards articulated by the FDA, the State Boards of Medicine or the State Boards of Nursing regarding TMS Operator qualification. Neuronetics, the manufacturer of the NeuroStar TMS Therapy systems holds that the device is so safe and well tolerated that anyone may be trained to be an effective and safe TMS Operator. Registered Nurse (RN)/Medical Doctor (MD) TMS Operators predominate in hospital, academic and institutional settings, whereas unlicensed allied health workers predominate in private practice settings. Using both quantitative and qualitative research methodologies, this study demonstrated the safety and tolerability of TMS therapy provided by non-RN/MD TMS Operators in our communities. This study suggests a role for a future prospective randomized controlled trial to demonstrate the efficacy of TMS provided by non-RN/MD TMS Operators.
|
Filename | Svensson TK(429-435).pdf |
Filesize | 236.07 kB |
Filetype | pdf (Mime Type: application/pdf) |
Creator | admin |
Created On: | 05/18/2015 00:00 |
Viewers | Everybody |
Maintained by | Editor |
Hits | 2205 Hits |
Last updated on | 05/28/2015 06:05 |
Homepage | |
CRC Checksum | |
MD5 Checksum |